CoQ10 Shows Promise For Hearts

FOOTNOTES

1. Freeman LM and Rush JE.  Nutrition and cardiomyopathy:  lessons from spontaneous animal models.  Curr Heart Fail Rep.  2007;4(2):84-90.

2. Hamlin RL and Buffington CAT.  Nutrition and the heart.  Veterinary Clinics of North America:  Small Animal Practice.  1989;19(3):527-538.

3. Freeman LM.  Interventional nutrition for cardiac disease.  Clinical Techniques in Small Animal Practice.  1998;13(4):232-237.

4. Rocha M and Victor VM.  Targeting antioxidants to mitochondria and cardiovascular diseases:  the effects of mitoquinone.  Med Sci Monit.  2007;13(7):RA132-RA145.

5. Bolcal CC, Yildirim V, Doganci S, et al.  Do N-acetylcystein, ß-glucan, and coenzyme Q10 mollify myocardial ischemia-reperfusion injury?  The Heart Surgery Forum.  2007;10(3):E222-E227.

6. Bolcal CC, Yildirim V, Doganci S, et al.  Do N-acetylcystein, ß-glucan, and coenzyme Q10 mollify myocardial ischemia-reperfusion injury?  The Heart Surgery Forum.  2007;10(3):E222-E227.

7. Haas RH.  The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease.  Mitochondrion.  2007;7S:S136-S145.

8. Haas RH.  The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease.  Mitochondrion.  2007;7S:S136-S145.

9. Bolcal CC, Yildirim V, Doganci S, et al.  Do N-acetylcystein, ß-glucan, and coenzyme Q10 mollify myocardial ischemia-reperfusion injury?  The Heart Surgery Forum.  2007;10(3):E222-E227.

10. Pepe S, Marasco SF, Haas SJ, et al.  Coenzyme Q10 in cardiovascular disease.  Mitochondrion.  2007;7S:S154-S167.

11. Haas RH.  The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease.  Mitochondrion.  2007;7S:S136-S145.

12. DeFrancesco TC, Atkins CE, and Keene BW.  Myocardial infarction complicating management of congestive heart failure in a dog.  J Am Anim Hosp Assoc.  1996;32(1):68-72.

13. Driehys S, Van Winkle TJ, Sammarco CD, et al.  Myocardial infarction in dogs and cats:  37 cases (1985-1994).  J Am Vet Med Associ.  1998;213(10):1444-1448.

14. Tarnow I, Falk T, Tidholm A, et al.  Hemostatic biomarkers in dogs with chronic congestive heart failure.  J Vet Intern Med.  2007;21:451-457.

15. Lin CS, Liu CY, Sun YL, et al.  Alteration of endogenous antioxidant enzymes in naturally occurring hypertrophic cardiomyopathy.  Biochem Mol Biol Int.  1997;43(6):1253-1263.

16. Baumer AT, Flesch M, Wang X, et al.  Antioxidative enzymes in human hearts with idiopathic dilated cardiomyopathy.  J Mol Cell Cardiol.  2000;32(1):121-130.

17. Sam F, Kerstetter DL, Pimental DR, et al.  Increased reactive oxygen species production and functional alterations in antioxidant enzymes in human failing myocardium.  J Card Fail.  2005;11(6):473-480.

18. Pepe S, Marasco SF, Haas SJ, et al.  Coenzyme Q10 in cardiovascular disease.  Mitochondrion.  2007;7S:S154-S167.

19. Pepe S, Marasco SF, Haas SJ, et al.  Coenzyme Q10 in cardiovascular disease.  Mitochondrion.  2007;7S:S154-S167.

20. Haas RH.  The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease.  Mitochondrion.  2007;7S:S136-S145.

21. Nukui K, Matsuoka Y, Yamagishi T, et al.  Safety assessment of PureSorb-Q ™40 in healthy subjects and serum coenzyme Q10 level in excessive dosing.  J Nutri Sci Vitamino.  2007;53:198-206.

22. Pepe S, Marasco SF, Haas SJ, et al.  Coenzyme Q10 in cardiovascular disease.  Mitochondrion.  2007;7S:S154-S167.

23. Shalansky S, Lynd L, Richardson K, et al.  Risk of warfarin-related bleeding events and supratherapeutic International Normalized Ratios associated with complementary and alternative medicine:  a longitudinal analysis.  Pharmacotherapy.  2007;27(9):1237-1247.

24. Zaghloul AA, Gurley B, Khan M, et al.  Bioavailability assessment of oral coenzyme Q10 formulations in dogs.  Drug Development and Industrial Pharmacy.  2002;28(10):1195-1200.

25. Kommuru TR, Gurley B, Khan MA, Reddy IK. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int J Pharm. 2001 Jan 16;212(2):233-46.

26. Hathcock JN and Shao A.  Risk assessment for coenzyme Q10 (ubiquinone).  Regulatory Toxicology and Pharmacology.  2006;45:282-288. 

<HOME>

Leave a Comment

Comments

Your email address will not be published. Required fields are marked *

Register

Sign-up for your account with Veterinary Practice News. Your account gives you unlimited free access to our Newsletter Archives and our Digital Editions of Veterinary Practice News.
Please check the box below to confirm you would like to be added to Kenilworth Media’s various e-mail communications (includes e-newsletters, a survey now and then, and offers to the veterinarian industry*).
 

Leave this empty:

*We do not sell your e-mail address to 3rd parties, we simply forward their offers to you. Of course, you always have the right to unsubscribe from any communications you receive from us, should you change your mind in the future.